Occurrence of the van genes in Enterococcus faecalis and Enterococcus faecium from clinical isolates in Korea

Archives of Pharmacal Research

Volumn 30, Issue 3, 2007, Pages 329-336

  Yang, Jaewook ^a   Lee, Dokyung ^b   Kim, Yuna ^b   Kang, Byungyong ^b   Kim, Kyungjae ^b   Ha, Namjoo ^b  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b Sahmyook University   (South Korea)

Author keywords

Enterococcus faecalis; Enterococcus faecium; Teicoplanin; Vancomycin; Vancomycin resistance genes

Indexed keywords

EID: 34147213569     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977614     Document Type: Article

References (34)

1. Aarestrup, F. M., Agerso, Y., Gerner-Smidt, P., Madsen, M., and Fensen, L. B., Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagn. Microbiol. Infect. Dis., 37, 127-137 (2000).
2. Arthur, M. and Courvalin, P., Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents. Chemother., 37, 1563-1571 (1993).
3. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., In Current protocols in molecular biology, val. 2. John Wiley & Sons, New York, N. Y. (1991).
4. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. Morbid Mortal Weekly Rep., 42, 597-599 (1993).
5. Clark, N. C., Teixeira, L. M., Facklam, R. R., and Tenover, F. C., Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance in enterococci. J. Clin. Microbiol., 36, 2294-2297 (1998).
6. Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C., and Murray, B. E., Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob. Agents. Chemother., 40, 2605-2609 (1996).
7. Courvalin, P., Combinatorial approach of bacteria to antibiotic resistance. Res. Microbiol., 150, 367-373 (1999).
8. Depardieu, F., Perichan, B., and Courvalin, P., Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J. Clin. Microbiol., 42, 5857-5860 (2004).
9. Devriese, L. A., Laurier, L., De, Herdt, P., and Haesebrouck, F., Enterococcal and streptococcal species isolated from faeces of calves, young cattle and dairy cows. J. Appl. Bacteriol., 72, 29-31 (1992).
10. Dutka-Malen, S., Leclercq, R., Coutant, V., Duval, J., and Courvalin, P., Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob. Agents. Chemother., 34, 1875-1879 (1990).
11. Edmond, M. B., Wallace, S. E., Mclish, D. K., Pfaller, M. A., Jones, R. N., and Wenzel, R. P., Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis., 29, 239-244 (1999).
12. Emori, T. G. and Gaynes, R. P., An overview of nosocomial infections, including the role of microbiology laboratory. Clin. Microb. Drug. Resist., 6, 313-318 (1993).
13. Evers, S., Reynolds, P. E., and Courvalin, P., Sequence of the vanB and dll genes encoding D-alanine:D-lactate and D-alanine:D-alanine ligases in vancomycin-resistant Enterococcus faecalis V583. Gene, 140, 97-102 (1994).
14. Facklam, R. R., Sahm, D. F., and Teixeira, L. M., Enterococcus. In: Murray, P. R. (Ed.), Manual of Clinical Microbiology. American Society for Microbiology, Washington D.C., 297-305 (1999).
15. Fraimow, H., Jungkind, K., Lander, D., Delso, D., and Dean, J., Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann. Intern. Med., 121, 22-26 (1994).
16. Hong, K. S., Kang, E. S., and Lee, M. A., Investigation of prevalence of vancomycin-resistant enterococci and genotypes of glycopeptide resistance using polymerase chain reaction. Korean J. Clin. Pathol., 18, 372-378 (1998).
17. Huyke, M. M., Sahm, D. F., and Gilmore, M. S., Multi-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg. Infect. Dis., 4, 239-249 (1998).
18. Kim, J. M. and Song, Y. G., Vancomycin-Resistant Enterococcal Infections in Korea. Yonsei Med. J., 39, 562-568 (1998).
19. Klare, I., Heier, H., Claus, H., Reissbrodt, R., and Witte, W., vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol. Lett., 125, 165-172 (1995).
20. Klare, I. and Witte, W., Glykopeptidresistente Enterokokken. Wien. Klin. Wochenschr. 109/9, 293-300 (1997).
21. Lecclercq, R., Derlot, E., Duval, J., and Courvalin, P., Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med., 319, 157-161 (1988).
22. Moellering, R. C., The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J. Antimicrob. Chemother., 28, 1-12 (1991).
23. Moellering, R. C., Emergence of Enterococcus as a significant pathogen. Clin. Infect. Dis., 14, 1173-1178 (1992).
24. Mundy, L. M., Sahm, D. F., and Gilmore, M., Relationship between enterococcal virulence and antimicrobial resistance. Clin. Microbiol. Rev., 13, 513-522 (2000).
25. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-sixth edition. Approved document M7-A6. Wayne (PA): NCCLS (2003).
26. Navarro, F. and Courvalin, P., Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob. Agents. Chemother., 38, 1788-1793 (1994).
27. Patel, R., Clinical impact of vancomycin-resistant enterococci. J. Antimicrob. Chemother., 51 (Suppl. S3), iii13-iii21 (2003).
28. Quintiliani, R. Jr., Evers, S., and Courvalin, P., The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J. Infec. Dis., 167, 1220-1223 (1993).
29. Sahm, D. F., Free, L., and Handwerger, S., Inducible and constitutive expression of vanC-1 encoded resistance to vancomycin in Enterococcus gallinarum. Antimicrob. Agents. Chemother., 39, 1480-1484 (1995).
30. Schentag, J. J., Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit. Crit. Care. Med., 29 (4 Suppl), N100-7 (2001).
31. Wegener, H. C., Aarestrup, F. M., Jensen, L. B., Hammerum, A. M., and Bager, F., Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg. Infect. Dis., 5, 329-335 (1999).
32. Witte, W., Impact of antibiotic use in animal feeding on resistance of bacterial pathogens in humans. Ciba. Found. Symp., 207, 61-71 (1997).
33. World Health Organization (WHO). WHO Global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001.2 (2001).
34. Yu, H. J., Lee, S. S., Lee, D. S., and Kim, H. B., Isolation of Lactobacillus plantarum HB1 from Tongchimi and its nitrite-scavenging effect. The Korean J. of Microbiol., 39, 192-196 (2003).